Scholarlink

<p>Prostate cancer (PCa) remains one of the most common cancers and the second leading cause of cancer-related morbidity in men worldwide. RNA-binding proteins (RBPs) have emerged as crucial regulators of gene expression via binding to RNAs and influencing their stability, localization, alternative splicing, and translation. Aberrant expression of RBPs causes various diseases, including cancer. Growing evidence has indicated that RBPs participate in PCa tumorigenesis, progression, and therapeutic resistance. Specifically, RBPs can regulate cancerous behaviors of the cells, including proliferation, apoptosis, migration, invasion, and metastasis. This review aims to provide a comprehensive overview of the biological functions of RBPs, as well as the mechanisms by which they contribute to PCa, highlighting their crucial role in regulating signaling pathways and AR signaling. Furthermore, we discuss the clinical applications of RBPs in PCa as both prognostic and diagnostic biomarkers, as well as their potential as therapeutic targets.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Mechanistic insights and clinical implications of RNA-binding proteins in prostate cancer

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月20日

查看全文
  • Sepide Javankiani,
  • Masoud Khodarahmi,
  • Foroozan Yarahmadi,
  • Seyedeh Tarlan Mirzohreh,
  • Saman Soltani Moghadam,
  • Pegah Kavousinia,
  • Sadegh Moradi,
  • Nahal Aghajamal Avval,
  • Mandana Baghdadi,
  • Nasibeh Sargazi Moghaddam,
  • Mahyar Khanlari Goodarzi,
  • Neda Zamen Milani,
  • Faeze Ahmadi Beni,
  • Qumars Behfar

摘要

Prostate cancer (PCa) remains one of the most common cancers and the second leading cause of cancer-related morbidity in men worldwide. RNA-binding proteins (RBPs) have emerged as crucial regulators of gene expression via binding to RNAs and influencing their stability, localization, alternative splicing, and translation. Aberrant expression of RBPs causes various diseases, including cancer. Growing evidence has indicated that RBPs participate in PCa tumorigenesis, progression, and therapeutic resistance. Specifically, RBPs can regulate cancerous behaviors of the cells, including proliferation, apoptosis, migration, invasion, and metastasis. This review aims to provide a comprehensive overview of the biological functions of RBPs, as well as the mechanisms by which they contribute to PCa, highlighting their crucial role in regulating signaling pathways and AR signaling. Furthermore, we discuss the clinical applications of RBPs in PCa as both prognostic and diagnostic biomarkers, as well as their potential as therapeutic targets.